25 Years of Clinical Excellence.
2 Therapeutic Areas.
1 Goal.

For a quarter-century, Indero has been the trusted CRO partner for biotech and pharmaceutical leaders across the globe, delivering precision, reliability, and innovation in dermatology and rheumatology clinical trials.

Test your knowledge in our 25th anniversary trivia quiz đŸ€“
for a chance to win a 500$ Amazon gift card!

circle_bg_out.png
circle_bg_out.png

A Timeline of Innovation

Explore our evolution from a small team with a big vision to a global CRO leader.

2000

2007

2019

2025

2000

Innovaderm Founding

Innovaderm began as a clinical research site specializing in dermatology, quickly earning a reputation for quality research and participant care.

2004

Established Strategic Partnerships

Innovaderm formed strategic alliances with research centers across North America, expanding access to high-quality dermatology sites.

2005

Expanded Management Services and Transition to CRO

Evolved into a Clinical Research Organization (CRO), initiating the management of Investigator-Initiated Studies (IIS), cosmetics, and Phase I topical studies, enhancing service offerings.

2014

Focus on Multicenter Studies

Strengthened CRO activities aimed at multicenter studies, enhancing operational efficiency and research outcomes.

2017

Introduction to Biostatistics

Added biostatistics services and launched first studies in Europe.

2021

Global Expansion

Innovaderm established CRO operations in Europe.

2022

Acquisition of Excelsus Statistics

Acquired Excelsus Statistics, enhancing biometrics capabilities across various therapeutic areas.

2024

Expanding & Embracing Rheumatology

We expanded our clinical expertise, now boasting European operational hubs in Poland, Spain, and Germany, with operational capabilities to conduct trials all across Europe. We also launched enhanced ï»żregulatory and clinical development consultation services. 

A Word from Our Founder

Vision, Grit, and Growth

Hear directly from our founder about the early days, the turning points, and what’s next for Indero.

Hear Dr. Robert Bissonnette

Curious About Where the Magic Happens?

Take a virtual tour of our offices

Voices of Indero

Meet the people who’ve helped build Indero from the ground up.

Hear From Indero Employees

Think You Know Indero?
Let’s Find Out.

The draw is now closed. Thank you for participating!
Congratulations to Vered Ram, the winner of the $500 Amazon gift card!

Jeff Smith

Chef de la direction
Linkedin

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.

Revolutionize Your Topical Trials

Efficacy insights in days, not months.

 Indero’s Early Phase 1 model enables sponsors to initiate topical studies that detect early pharmacodynamic signals much sooner than traditional phase 1, using microdosing and transcriptomic analysis. This approach reduces preclinical requirements, shortens study duration from 8–12 weeks to ≀3 days, and lowers costs, helping teams make informed go/no-go decisions faster.
LEARN MORE >